Announcement on Obtaining Philippine Drug Registration Certificate for Aripiprazole Tablets
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Obtaining Philippine Drug Registration Certificate for Aripiprazole Tablets
Filed with SSE · · 2 pages · Chinese
Release
Shanghai Pharmaceuticals Holding Co. Ltd. on 6ix
Earlier from Shanghai Pharmaceuticals
- Announcement on Diprophylline Injection Passing Generic Drug Consistency Evaluation
- Announcement on Verapamil Hydrochloride Injection Passing Generic Drug Consistency Evaluation
- 2025 Semi-annual Report
- Announcement on Obtaining Philippine Drug Registration Certificate for Oxytocin Injection and Octreotide Acetate Injection
- Announcement on the Receipt of Clinical Trial Approval Notice for a New Indication of B019
Later from Shanghai Pharmaceuticals
- Announcement on Shareholding Increase Plan for the Controlling Shareholder
- Announcement on Nicorandil Tablet Passing Generic Drug Consistency Evaluation
- Indicative Announcement on Changes in Shareholder's Equity
- Announcement on Resignation of Senior Management Members
- Announcement on Independent Exercise Results of Reserved Stock Options in the 3rd Vesting Period of 2019 A-share Stock Option Incentive Plan and in Q3 2025
Follow Shanghai Pharmaceuticals into a list and get an email when it puts out news.
Follow Shanghai Pharmaceuticals